My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

17.01 +1.19 (+7.52%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fortrea Holdings Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call

April 11, 2024

From Fortrea Holdings Inc

Via GlobeNewswire

Where Fortrea Holdings Stands With Analysts ↗

March 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 11, 2024

Via Benzinga

Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance

March 11, 2024

From Fortrea Holdings Inc

Via GlobeNewswire

Key Takeaways From Fortrea Holdings Analyst Ratings ↗

March 06, 2024

Via Benzinga

Expert Outlook: Fortrea Holdings Through The Eyes Of 5 Analysts ↗

January 25, 2024

Via Benzinga

Where Fortrea Holdings Stands With Analysts ↗

January 04, 2024

Via Benzinga

The Latest Analyst Ratings for Fortrea Holdings ↗

December 01, 2023

Via Benzinga

Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

March 11, 2024

From Fortrea Holdings Inc

Via GlobeNewswire

Earnings Scheduled For March 11, 2024 ↗

March 11, 2024

Companies Reporting Before The Bell • Ballard Power Systems (NASDAQ:BLDP) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million.

Via Benzinga

Oracle, Casey's General Stores And 3 Stocks To Watch Heading Into Monday ↗

March 11, 2024

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Why Fortrea Holdings Shares Are Gaining Today ↗

October 17, 2023

Activist hedge fund Starboard Value holds a

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 08, 2024

Via Benzinga

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for February 2024 ↗

February 21, 2024

Biotech stocks are often at the forefront of innovation. These picks are worth considering for your portfolio for their growth potential.

Via InvestorPlace

Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion

February 20, 2024

Fortrea’s non-commercial specialty pharmacy expansion delivers flexible, scalable solutions to customers and life-changing medications direct to patients

From Fortrea Holdings Inc

Via GlobeNewswire

Fortrea to Present at the Barclays 26th Annual Global Healthcare Conference

February 20, 2024

From Fortrea Holdings Inc

Via GlobeNewswire

Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference Call

January 29, 2024

From Fortrea Holdings Inc

Via GlobeNewswire

Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clinical Trial Experience

January 09, 2024

Companies partner to provide patients and sites with easy access to study information in one integrated solution

From Fortrea Holdings Inc

Via GlobeNewswire

Fortrea Previews J.P. Morgan Healthcare Conference Updates

January 08, 2024

From Fortrea Holdings Inc

Via GlobeNewswire

Fortrea to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 02, 2024

From Fortrea Holdings Inc

Via GlobeNewswire

Are November’s 3 Biggest Stock Losers Worth Snapping Up Now? ↗

December 17, 2023

The market was like an iceberg with only a few winners showing but that means there are a lot of the biggest stock losers worth getting now.

Via InvestorPlace

Fortrea Convenes New Site Advisory Board

December 13, 2023

Fortrea’s Site Advisory Board brings research leaders together to focus on evolving site, sponsor and patient relationships

From Fortrea Holdings Inc

Via GlobeNewswire

Why Is Inflammation Disease Focused Acelyrin Stock Trading Lower Today? ↗

November 28, 2023

Acelyrin Inc (NASDAQ: SLRN) updated its izokibep clinical development program, including its ongoing global Phase 2b/3 trial for izokibep in

Via Benzinga

Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials

November 20, 2023

Collaboration leverages Medidata AI to improve access and participation of diverse population groups in clinical studies

From Fortrea Holdings Inc

Via GlobeNewswire

Why Fortrea Holdings Stock Climbed Nearly 10% Higher Today ↗

November 13, 2023

The company's first quarter as a separate entity was better than anticipated.

Via The Motley Fool

Monday.Com Reports Q3 Beat, Joins Fortrea Holdings, Henry Schein And Other Big Stocks Moving Higher On Monday ↗

November 13, 2023

U.S. stocks traded lower, with the Dow Jones falling around 40 points on Monday.

Via Benzinga

Topics Stocks

Earnings Scheduled For November 13, 2023 ↗

November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.

Via Benzinga

Fortrea Reports Third Quarter 2023 Results

November 13, 2023

From Fortrea Holdings Inc

Via GlobeNewswire

Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K.

November 02, 2023

Adds speed and agility with cGMP production at on-site pharmacies, adds capacity, improves flexible therapeutic capabilities and enhances experience for study volunteers

From Fortrea Holdings Inc

Via GlobeNewswire

Starboard Value Issues Presentation Delivered at 13D Monitor’s 2023 Active-Passive Investor Summit

October 17, 2023

From Starboard Value LP

Via Business Wire

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.